folate receptor alpha CAR-T

N/A

Report date: 2025/03/20 15:10:39

Base Information

Drug Namefolate receptor alpha CAR-T
Drug Alias Nameanti-folate receptor alpha CAR T-cell therapy (Kite Pharma)anti-folate receptor alpha CAR T-cell therapy (Tmunity)
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapyBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionFolate receptor alpha modulators
TargetsFolate receptor alpha
Therapy Area/IndicationsOvarian Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTmunity Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesKite Pharma Inc
Inactive CompaniesTmunity Therapeutics Inc
Active IndicationsOvarian Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A